1. Home
  2. NTHI vs GHG Comparison

NTHI vs GHG Comparison

Compare NTHI & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$3.35

Market Cap

106.0M

Sector

Health Care

ML Signal

HOLD

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$1.00

Market Cap

102.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
NTHI
GHG
Founded
2008
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
106.0M
102.9M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
NTHI
GHG
Price
$3.35
$1.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $15.00
N/A
AVG Volume (30 Days)
★ 179.9K
8.2K
Earning Date
05-19-2026
04-29-2026
Dividend Yield
N/A
★ 4.15%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $39,990.00
N/A
Revenue This Year
N/A
$19.02
Revenue Next Year
N/A
$8.26
P/E Ratio
★ N/A
$5.76
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$0.99
52 Week High
$12.99
$2.31

Technical Indicators

Market Signals
Indicator
NTHI
GHG
Relative Strength Index (RSI) 41.18 33.64
Support Level $3.03 $0.99
Resistance Level $3.70 $1.12
Average True Range (ATR) 0.42 0.03
MACD -0.06 -0.00
Stochastic Oscillator 15.74 11.11

Price Performance

Historical Comparison
NTHI
GHG

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

Share on Social Networks: